BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $644,000 | +198.1% | 4,426 | +142.8% | 0.00% | – |
| Q1 2022 | $216,000 | -86.6% | 1,823 | -90.3% | 0.00% | -100.0% |
| Q4 2020 | $1,609,000 | +54.9% | 18,776 | +17.4% | 0.00% | +100.0% |
| Q3 2020 | $1,039,000 | +602.0% | 15,992 | +267.0% | 0.00% | – |
| Q1 2020 | $148,000 | -80.7% | 4,357 | -76.3% | 0.00% | -100.0% |
| Q3 2019 | $766,000 | -67.9% | 18,374 | -66.2% | 0.00% | -71.4% |
| Q2 2019 | $2,383,000 | +27.1% | 54,434 | +49.3% | 0.01% | +40.0% |
| Q1 2019 | $1,875,000 | +591.9% | 36,448 | +396.7% | 0.01% | +400.0% |
| Q4 2018 | $271,000 | +72.6% | 7,338 | +75.3% | 0.00% | 0.0% |
| Q3 2018 | $157,000 | +35.3% | 4,186 | +41.7% | 0.00% | – |
| Q2 2018 | $116,000 | -80.3% | 2,954 | -87.1% | 0.00% | -100.0% |
| Q1 2018 | $588,000 | +818.8% | 22,855 | +849.9% | 0.03% | +766.7% |
| Q4 2017 | $64,000 | – | 2,406 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |